Papers associated with slc10a1

???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	Identification of Triterpene Acids in Poria cocos Extract as Bile Acid Uptake Transporter Inhibitors., Cai H, Cheng Y, Zhu Q, Kong D, Chen X, Tamai I, Lu Y., Drug Metab Dispos. May 1, 2021; 49 (5): 353-360.
	Expression, sorting and transport studies for the orphan carrier SLC10A4 in neuronal and non-neuronal cell lines and in Xenopus laevis oocytes., Schmidt S, Moncada M, Burger S, Geyer J., BMC Neurosci. June 19, 2015; 16 35.
	Electrophysiological characterization of human Na⁺/taurocholate cotransporting polypeptide (hNTCP) heterologously expressed in Xenopus laevis oocytes., Masuda M, Ichikawa Y, Shimono K, Shimizu M, Tanaka Y, Nara T, Miyauchi S., Arch Biochem Biophys. November 15, 2014; 562 115-21.
	Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green., de Graaf W, Häusler S, Heger M, van Ginhoven TM, van Cappellen G, Bennink RJ, Kullak-Ublick GA, Hesselmann R, van Gulik TM, Stieger B., J Hepatol. April 1, 2011; 54 (4): 738-45.
	Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovir., Moss DM, Kwan WS, Liptrott NJ, Smith DL, Siccardi M, Khoo SH, Back DJ, Owen A., Antimicrob Agents Chemother. February 1, 2011; 55 (2): 879-87.
	Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors., Choi MK, Shin HJ, Choi YL, Deng JW, Shin JG, Song IS., Xenobiotica. January 1, 2011; 41 (1): 24-34.
	Inhibition of Na+-taurocholate Co-transporting polypeptide-mediated bile acid transport by cholestatic sulfated progesterone metabolites., Abu-Hayyeh S, Martinez-Becerra P, Sheikh Abdul Kadir SH, Selden C, Romero MR, Rees M, Marschall HU, Marin JJ, Williamson C., J Biol Chem. May 28, 2010; 285 (22): 16504-12.
	In vitro inhibition of OATP-mediated uptake of phalloidin using bile acid derivatives., Herraez E, Macias RI, Vazquez-Tato J, Vicens M, Monte MJ, Marin JJ., Toxicol Appl Pharmacol. August 15, 2009; 239 (1): 13-20.
	Cloning and molecular characterization of the orphan carrier protein Slc10a4: expression in cholinergic neurons of the rat central nervous system., Geyer J, Fernandes CF, Döring B, Burger S, Godoy JR, Rafalzik S, Hübschle T, Gerstberger R, Petzinger E., Neuroscience. April 9, 2008; 152 (4): 990-1005.
	Novel cationic and neutral glycocholic acid and polyamine conjugates able to inhibit transporters involved in hepatic and intestinal bile acid uptake., Vicens M, Medarde M, Macias RI, Larena MG, Villafaina A, Serrano MA, Marin JJ., Bioorg Med Chem. March 15, 2007; 15 (6): 2359-67.
	Inhibition of the intestinal absorption of bile acids using cationic derivatives: mechanism and repercussions., Vicens M, Macias RI, Briz O, Rodriguez A, El-Mir MY, Medarde M, Marin JJ., Biochem Pharmacol. February 1, 2007; 73 (3): 394-404.
	Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokinetics., Smith NF, Marsh S, Scott-Horton TJ, Hamada A, Mielke S, Mross K, Figg WD, Verweij J, McLeod HL, Sparreboom A., Clin Pharmacol Ther. January 1, 2007; 81 (1): 76-82.
	Carrier-mediated hepatic uptake of a novel nonrenal excretion type uric acid generation inhibitor, Y-700., Sai Y, Kato Y, Nakamura K, Kato S, Nishimura T, Kubo Y, Tamai I, Yang S, Hu Z, Yamada I, Tsuji A., J Pharm Sci. February 1, 2006; 95 (2): 336-47.
	Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase., Fujino H, Saito T, Ogawa S, Kojima J., J Pharm Pharmacol. October 1, 2005; 57 (10): 1305-11.
	Thyroid hormone transporters., Friesema EC, Jansen J, Milici C, Visser TJ., Vitam Horm. January 1, 2005; 70 137-67.
	Identification of phalloidin uptake systems of rat and human liver., Meier-Abt F, Faulstich H, Hagenbuch B., Biochim Biophys Acta. July 1, 2004; 1664 (1): 64-9.
	Transport of taurocholate by mutants of negatively charged amino acids, cysteines, and threonines of the rat liver sodium-dependent taurocholate cotransporting polypeptide Ntcp., Zahner D, Eckhardt U, Petzinger E., Eur J Biochem. March 1, 2003; 270 (6): 1117-27.
	Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells., Briz O, Serrano MA, Rebollo N, Hagenbuch B, Meier PJ, Koepsell H, Marin JJ., Mol Pharmacol. April 1, 2002; 61 (4): 853-60.
	Basolateral and canalicular transport of xenobiotics in the hepatocyte: A review., Diaz GJ., Cytotechnology. November 1, 2000; 34 (3): 225-35.
	Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2., Fattinger K, Cattori V, Hagenbuch B, Meier PJ, Stieger B., Hepatology. July 1, 2000; 32 (1): 82-6.
	Molecular cloning and functional characterization of two alternatively spliced Ntcp isoforms from mouse liver1., Cattori V, Eckhardt U, Hagenbuch B., Biochim Biophys Acta. April 14, 1999; 1445 (1): 154-9.
	Identification of thyroid hormone transporters., Friesema EC, Docter R, Moerings EP, Stieger B, Hagenbuch B, Meier PJ, Krenning EP, Hennemann G, Visser TJ., Biochem Biophys Res Commun. January 19, 1999; 254 (2): 497-501.
	Substrate specificity of the rat liver Na(+)-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells., Schroeder A, Eckhardt U, Stieger B, Tynes R, Schteingart CD, Hofmann AF, Meier PJ, Hagenbuch B., Am J Physiol. February 1, 1998; 274 (2): G370-5.
	Substrate specificity of the rat liver Na + -bile salt cotransporter in Xenopus laevis oocytes and in CHO cells., Schroeder A, Eckhardt U, Stieger B, Tynes R, Schteingart CD, Hofmann AF, Meier PJ, Hagenbuch B., Am J Physiol Gastrointest Liver Physiol. February 1, 1998; 274 (2): G370-G375.
	Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas., Kullak-Ublick GA, Glasa J, Böker C, Oswald M, Grützner U, Hagenbuch B, Stieger B, Meier PJ, Beuers U, Kramer W, Wess G, Paumgartner G., Gastroenterology. October 1, 1997; 113 (4): 1295-305.
	Functional re-evaluation of the putative glutathione transporters, RcGshT and RsGshT., Li L, Lee TK, Ballatori N., Yale J Biol Med. January 1, 1997; 70 (4): 301-10.
	The peptide-based thrombin inhibitor CRC 220 is a new substrate of the basolateral rat liver organic anion-transporting polypeptide., Eckhardt U, Horz JA, Petzinger E, Stüber W, Reers M, Dickneite G, Daniel H, Wagener M, Hagenbuch B, Stieger B, Meier PJ., Hepatology. August 1, 1996; 24 (2): 380-4.
	Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes., Hagenbuch B, Scharschmidt BF, Meier PJ., Biochem J. June 15, 1996; 316 ( Pt 3) 901-4.
	Review article: new insights into the mechanisms of hepatic transport and bile secretion., Erlinger S., J Gastroenterol Hepatol. June 1, 1996; 11 (6): 575-9.
	Sinusoidal (basolateral) bile salt uptake systems of hepatocytes., Hagenbuch B, Meier PJ., Semin Liver Dis. May 1, 1996; 16 (2): 129-36.
	Bumetanide is not transported by the Ntcp or by the oatp: evidence for a third organic anion transporter in rat liver cells., Horz JA, Honscha W, Petzinger E., Biochim Biophys Acta. April 19, 1996; 1300 (2): 114-8.
	Mechanisms of hepatic transport and bile secretion., Erlinger S., Acta Gastroenterol Belg. January 1, 1996; 59 (2): 159-62.
	Hepatobiliary elimination of certain peptide-mimicking drugs: linear hydrophobic and hydrophilic renin-inhibitors and hydrophobic cyclopeptides., Ziegler K, Kolac C, Schulze S, Wenzel U, Kemmer H., J Hepatol. January 1, 1996; 24 Suppl 1 47-52.
	Hepatobiliary transport of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors conjugated with bile acids., Petzinger E, Nickau L, Horz JA, Schulz S, Wess G, Enhsen A, Falk E, Baringhaus KH, Glombik H, Hoffmann A., Hepatology. December 1, 1995; 22 (6): 1801-11.
	Relationship between the microsomal epoxide hydrolase and the hepatocellular transport of bile acids and xenobiotics., Honscha W, Platte HD, Oesch F, Friedberg T., Biochem J. November 1, 1995; 311 ( Pt 3) 975-9.
	Characterization of cloned rat liver Na(+)-bile acid cotransporter using peptide and fusion protein antibodies., Ananthanarayanan M, Ng OC, Boyer JL, Suchy FJ., Am J Physiol. October 1, 1994; 267 (4 Pt 1): G637-43.
	Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter., Hagenbuch B, Meier PJ., J Clin Invest. March 1, 1994; 93 (3): 1326-31.

???pagination.result.page??? 1